Indian shares inched larger on Thursday, led by power in client items and pharmaceutical shares, though fears that the U.S. Federal Reserve would go for extra aggressive charge hikes attributable to hovering inflation stored a lid on positive factors.
The NSE Nifty 50 index was up 0.2% at 16,004, as of 0359 GMT, whereas the S&P BSE Sensex rose 0.18% to 53,607.90.
U.S. client costs accelerated in June, ensuing within the largest annual enhance in inflation in 40-1/2 years and cementing the case for the Fed to hike rates of interest by 75 foundation factors later this month.
A stronger home inflation knowledge earlier this week additionally boosted prospects of extra charge hikes by the Reserve Bank of India subsequent month.
The Indian rupee hit a file low for the fourth straight session in opposition to the greenback on extra safe-haven flows into the dollar and outflows from home equities.
The Nifty pharma index rose 1%, whereas the fast- shifting client good index gained 0.6%.
